ClinicalTrials.gov record
Completed Phase 1 Interventional

Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery

ClinicalTrials.gov ID: NCT03317119

Public ClinicalTrials.gov record NCT03317119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Clinical Trial of Trametinib in Combination With TAS-102 in Patients With Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild-Type) Metastatic Colorectal Cancer

Study identification

NCT ID
NCT03317119
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
City of Hope Medical Center
Other
Enrollment
26 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 10, 2018
Primary completion
Jul 13, 2023
Completion
Jul 13, 2023
Last update posted
Apr 7, 2024

2018 – 2023

United States locations

U.S. sites
8
U.S. states
1
U.S. cities
8
Facility City State ZIP Site status
City of Hope Corona Corona California 92879
City of Hope Medical Center Duarte California 91010
City of Hope Antelope Valley Lancaster California 93534
City of Hope Mission Hills Mission Hills California 91345
City of Hope Rancho Cucamonga Rancho Cucamonga California 91730
City of Hope - Santa Clarita Santa Clarita California 91355
City of Hope South Pasadena South Pasadena California 91030
City of Hope West Covina West Covina California 91790

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03317119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2024 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03317119 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →